SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Intermolecular, Inc. to Merck KGaA, Darmstadt, Germany is Fair to Shareholders

Monday, 06. May 2019 15:56

NEW YORK, May 06, 2019 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Intermolecular, Inc. (“Intermolecular” or the “Company”) (NASDAQGS: IMI) stock prior to May 6, 2019.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Intermolecular to Merck KGaA, Darmstadt, Germany. Under the terms of the transaction, Intermolecular shareholders will receive $1.20 per share in cash for each share of Intermolecular stock they own. To learn more about the action and your rights, go to:

https://www.zlk.com/mna/intermolecular-inc

 or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The Intermolecular merger investigation concerns whether the Board of Intermolecular breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Merck KGaA, Darmstadt, Germany is underpaying for Intermolecular shares, thus unlawfully harming Intermolecular shareholders.

Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

250x148_zlk.jpg

Related Links: 
Author:
Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.